Flow Neuroscience develops a non-invasive transcranial direct current stimulation headset designed to treat depression at home. The company highlights clinical validation, NHS adoption, and independent trials backing its method, with availability across Europe, the UK, and other regions. Their product combines brain stimulation with a companion app to track mood and symptoms, offering a medication-free option for adults with mild to severe depression. Flow emphasizes safety, patient support, and a 30-day money-back guarantee, positioning itself as a clinically supported at-home depression treatment.
No recent news for this company.
No recent deals for this company.